Media & Resources

Filter by

  • Type

  • Health area

  • Location

  • Topic

  • Year

  • Journal

  • Publication

  • Fact sheet & publication type

  • Clear all

Features

Meet the Scientist: Dr. Gaudensia Mutua on IAVI’s Lassa fever vaccine development program

December 20, 2024

Gaudensia Mutua, a medical director with IAVI in Nairobi, Kenya, discusses her work in support of IAVI’s Lassa fever vaccine program.

Read more

Features

Access to monoclonal antibodies in Africa: A call to action

December 17, 2024

IAVI and Impact Global Health issue a renewed call to action to ensure equitable access to monoclonal antibodies.

Read more

Features

Outthinking and outsmarting HIV to outdo an epidemic

December 3, 2024

Can we outsmart a virus so clever and evasive that it has challenged scientists for decades? My research seeks answers to these pressing questions.

Read more

Features

IAVI commemorates World AIDS Day in a landmark year for HIV prevention

December 2, 2024

Long-acting PrEP offers tremendous hope for prevention, but a vaccine remains necessary to end HIV as a public health threat.

Read more

Features

IAVI at the 2024 ASTMH Annual Meeting

November 8, 2024

IAVI’s strong presence at the TropMed conference will showcase the expansion of our emerging infectious diseases program and enable critical dialogue with our global health peers.

Read more

Features

IAVI at the World Vaccine Congress Europe

October 23, 2024

IAVI leaders will chair sessions and share the latest on our emerging infectious diseases program, vaccine innovation, and more at Europe’s largest vaccine conference.

Read more

Features

IAVI reflects on the changing HIV prevention landscape at HIVR4P 2024

October 18, 2024

Cross-disciplinary conversations highlighted recent progress in HIV vaccine and antibody research, as well as the importance of choice and community collaboration when developing HIV prevention strategies.

Read more

Features

Join IAVI at the 7th Global Forum on TB Vaccines

October 2, 2024

IAVI leaders to represent the full breadth of TB vaccine research, development, implementation, advocacy, and policy at the 7th Global Forum in Rio.

Read more